ACHIEVE LIFE SCIENCES, INC.
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Nov 5, 2026 (9 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 30, 2026 | Stifel | initiate | — → Buy | — | 53% |
| Aug 13, 2026 | Morgan Stanley | initiate | — → Overweight | — | 54% |
| Jun 22, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 21, 2026 | Canaccord Genuity | initiate | — → Buy | — | 48% |
| Apr 16, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 25, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Nov 25, 2025 | Citizens | initiate | — → Market Outperform | $19 | 47% |
| Aug 21, 2025 | HC Wainwright & Co. | initiate | — → Buy | $12 | 44% |
| Nov 14, 2024 | Rodman & Renshaw | initiate | — → Buy | $12 | 40% |
| Aug 15, 2024 | Oppenheimer | reiterate | Outperform → Outperform | $11 | 52% |
| May 13, 2024 | Oppenheimer | maintain | Outperform → Outperform | $11 | 52% |
| Apr 17, 2024 | JonesTrading | initiate | — → Buy | $20 | 75% |
| Apr 1, 2024 | Oppenheimer | reiterate | Outperform → Outperform | $18 | 52% |
| Mar 5, 2024 | Lake Street | maintain | Buy → Buy | $11 | 47% |
| Dec 12, 2023 | Oppenheimer | maintain | Outperform → Outperform | $18 | 52% |
| May 31, 2023 | Lake Street | maintain | Buy → Buy | $19 | 47% |
| May 10, 2023 | Lake Street | maintain | Buy → Buy | $22 | 47% |
| Mar 17, 2023 | Oppenheimer | reiterate | — → Outperform | $17 | 52% |
| Nov 16, 2022 | Maxim Group | maintain | — → Buy | $8 | 41% |
| Oct 4, 2021 | Alliance Global Partners | initiate | — → Buy | $25 | 41% |
| Jun 23, 2021 | Oppenheimer | initiate | — → Outperform | $23 | 52% |
| Sep 17, 2020 | Lake Street | initiate | — → Buy | $30 | 47% |
| Feb 25, 2020 | HC Wainwright & Co. | initiate | — → Buy | $2 | 44% |
| Jun 14, 2019 | Maxim Group | initiate | — → Buy | $6 | 41% |
No cross-platform signals in the last 90 days